$268.52
0.25%
NYSE, Sep 02, 04:15 pm CET
ISIN
US9224751084
Symbol
VEEV

Veeva Systems Inc Class A Stock News

Neutral
PRNewsWire
about 4 hours ago
Advanced regulatory capabilities and new industry partnerships accelerate collaboration with global health authorities PLEASANTON, Calif. , Sept. 2, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced more than 450 companies, including 19 of the top 20 biopharmas, have adopted Veeva RIM for regulatory information management (RIM) on a unified platform.
Positive
Seeking Alpha
5 days ago
Veeva Systems delivered strong Q2 results, with robust revenue growth and a fortress-like balance sheet, reinforcing its leadership in the biopharma sector. The company resolved its legal dispute with IQVIA, forming a partnership that reduces uncertainty and has been well-received by customers. Despite premium valuation metrics, Veeva's high margins and continued growth justify its current mult...
Neutral
PRNewsWire
5 days ago
PLEASANTON, Calif. , Aug. 28, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced a collaboration with Amgen to advance clinical trial innovation.
Neutral
Seeking Alpha
5 days ago
Veeva Systems Inc. (NYSE:VEEV ) Q2 2026 Earnings Conference Call August 27, 2025 5:00 PM ET Company Participants Brian Van Wagener - Chief Financial Officer Gunnar Georg Hansen - Director of Investor Relations Paul Shawah - Executive Vice President of Strategy & Campaign Manager Peter P. Gassner - Founder, CEO & Director Conference Call Participants Andrew Lodovico DeGasperi - BNP Paribas Exane...
Negative
Investors Business Daily
6 days ago
Veeva stock dipped late Wednesday after the firm reported adjusted earnings of $1.99 per share on $789.1 million in second-quarter sales.
Neutral
PRNewsWire
6 days ago
Total Revenues of $789.1M, up 17% Year Over Year Subscription Services Revenues of $659.2M, up 17% Year Over Year PLEASANTON, Calif. , Aug. 27, 2025 /PRNewswire/ -- Veeva Systems Inc. (NYSE: VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its second quarter ended July 31, 2025.
Neutral
PRNewsWire
12 days ago
Alnylam Pharmaceuticals, BeOne Medicines, Intercept Pharmaceuticals, Merck, Pfizer, and Sanofi among biopharmas sharing strategies that set future direction Veeva to showcase innovations, including deep industry-specific Veeva AI in Vault Platform and Veeva applications PLEASANTON, Calif. , Aug. 21, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced highlights of its upcoming Veeva...
Neutral
PRNewsWire
15 days ago
Global partnerships to help customers improve clinical and commercial efficiency and effectiveness RESEARCH TRIANGLE PARK, N.C. and PLEASANTON, Calif.

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today